🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

61 notícias encontradas para "anderson"
Jonathan Anderson mostra coleção da Dior em clima de festa e calor em Paris
Ternos desconstruídos e detalhes de fantasia. Jonathan Anderson apresentou nesta quarta-feira (24) sua terceira coleção masculina para a Dior, em clima de festa, mas em plena onda de calor na França. Leia mais (06/24/2026 - 10h19)
Foto: Anna Tarazevich / Pexels
Taylor Swift escolheu Dior para criar seu vestido de casamento com Travis Kelce
O mistério sobre o vestido de casamento de Taylor Swift chegou ao fim. Um representante da cantora confirmou ao The New York Times que a peça foi criada por Jonathan Anderson, diretor criativo da Dior. Segundo o comunicado enviado ao jornal, o modelo é o "primeiro vestido de noiv
Immune ecotypes may explain multiple myeloma outcomes missed by disease staging
Immune ecotypes may explain multiple myeloma outcomes missed by disease staging
Researchers at The University of Texas MD Anderson Cancer Center have created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions. The study provided insights that may explain why patients with similar diagnoses of
AI-guided pathology analysis can help predict immunotherapy response in rare cancers
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in a study of patients with rare cancers, published in the Journal for ImmunoTherapy of Can
Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.
Two prostate cancer mutations reveal opposite responses to ferroptosis therapy
A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guid
Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic
Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATR
Full-fat dairy shows benefits without raising body fat or cholesterol, study finds
Full-fat dairy shows benefits without raising body fat or cholesterol, study finds
A Canadian study led by University of Toronto researcher Harvey Anderson is offering new evidence in support of consuming full-fat dairy. The findings, published recently in the Journal of Nutrition, demonstrate that three daily servings of full-fat dairy can be incorporated into
Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients wit
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating them with the antibody-drug conju
Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy
Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro
Epigenetic therapy shows promise against treatment-resistant AML
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML) by activating the Hippo pathway, a tumor-suppressing pathway linked to cancer growth
KRAS-targeting drugs show promise for rare appendix cancer
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.